术中冰冻切片识别前列腺癌根治术后生化复发风险患者
本研究基于883例连续接受前列腺癌根治术的患者,术中常规使用全mount冰冻切片检查切缘,必要时切除更多前列腺周围组织。中位随访22.4个月,二次肿瘤切除标本中残留前列腺癌的患者生化复发风险显著高于初始切缘阴性者(HR 1.99,95%CI 1.01-3.92;P=0.046)。
要点
- 术中冰冻切片初始切缘阴性者1年无生化复发生存率为93.4%。
- 二次切除标本有残留癌者1年无生化复发生存率81.0%,显著低于初始切缘阴性者。
- 二次切除标本有残留癌是生化复发的独立危险因素(HR 1.99)。
核心结论
- 尽管最终切缘阴性,二次肿瘤切除标本中残留前列腺癌的患者生化复发风险仍较高。
- 该亚组患者需要更密切的术后监测。
研究设计与样本
- 回顾性队列研究,纳入883例连续接受前列腺癌根治术的患者。
- 术中常规使用全mount冰冻切片检查切缘,必要时行二次肿瘤切除以达到阴性切缘。
- 排除淋巴结阳性或最终切缘阳性的患者。
主要发现
- 中位随访22.4个月。
- 初始切缘阴性者1年和2年无生化复发生存率分别为93.4%和90.9%。
- 二次切除标本有残留癌者1年和2年无生化复发生存率分别为81.0%和72.9%(P=0.001)。
- 二次切除标本无残留癌者1年和2年无生化复发生存率分别为90.3%和82.3%(P=0.033)。
- 多因素Cox回归显示,二次切除标本残留癌与生化复发风险升高相关(HR 1.99,95%CI 1.01-3.92;P=0.046)。
临床怎么用
- 术后应识别二次切除标本中残留前列腺癌的患者,并加强生化复发监测。
- 未来研究应关注该高危亚组是否受益于早期挽救治疗。
局限性
- 中位随访时间较短(22.4个月)。
- 为单中心回顾性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify patients at risk for biochemical recurrence (BCR) of prostate cancer (PCa) after radical prostatectomy (RP) with intra-operative whole-mount frozen section (FS) of the prostate. MATERIAL AND METHODS: We examined differences in BCR between patients with initial negative surgical margins at FS, patients with final negative surgical margins with initial positive margins at FS without residual PCa after secondary tumour resection, and patients with final negative surgical margins with initially positive margins at FS with residual PCa in the secondary tumour resection specimen. Institutional data of 883 consecutive patients undergoing RP were collected. Intra-operative whole-mount FS was routinely used to check for margin status and, if necessary, to resect more periprostatic tissue in order to achieve negative margins. Patients with lymph node-positive disease or final positive surgical margins were excluded from the analysis. Kaplan-Meier curves and multivariable Cox proportional hazards regression analyses adjusting for clinical covariates were employed to examine differences in biochemical recurrence-free survival (BRFS) according to the resection status mentioned above. RESULTS: The median follow-up was 22.4 months. The 1- and 2-year BRFS rates in patients with (81.0% and 72.9%, respectively; P = 0.001) and without residual PCa (90.3% and 82.3%, respectively; P = 0.033) after secondary tumour resection were significantly lower compared to patients with initial R0 status (93.4% and 90.9%, respectively). On multivariable Cox regression only residual PCa in the secondary tumour resection was associated with a higher risk of BCR compared to initial R0 status (hazard ratio 1.99, 95% confidence interval 1.01-3.92; P = 0.046). CONCLUSION: Despite being classified as having a negative surgical margin, patients with residual PCa in the secondary tumour resection specimen face a high risk of BCR. These findings warrant closer post-RP surveillance of this particular subgroup. Further research of this high-risk subset of patients should focus on examining whether these patients benefit from early salvage therapy and how resection status impacts oncological outcomes in the changing landscape of PCa treatment.
引用
- Tully KH, Schulmeyer M, Hanske J, et al. Identification of patients at risk for biochemical recurrence after radical prostatectomy with intra-operative frozen section. BJU Int. 2021. PMID: 33961328. doi:10.1111/bju.15446
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。